ReviewJournal of hematology & oncology2012

Splenomegaly in myelofibrosis--new options for therapy and the therapeutic potential of Janus kinase 2 inhibitors.

Jasleen Randhawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.